AXDX - Accelerate Diagnostics, Inc

0.034
-0.054   -158.824%

Share volume: 67,483,332
Last Updated: 05-14-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.06%

PREVIOUS CLOSE
CHG
CHG%
$0.09
-0.05
-0.61%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
24%
Profitability 0%
Dept financing 25%
Liquidity 53%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-93.81%
6 Months
-96.82%
1 Year
-97.07%
2 Year
-99.51%
Key data
Stock price
$0.03
P/E Ratio 
0.00
DAY RANGE
$0.03 - $0.08
EPS 
-$2.24
52 WEEK RANGE
$0.03 - $2.09
52 WEEK CHANGE
-$96.99
MARKET CAP 
30.053 M
YIELD 
N/A
SHARES OUTSTANDING 
23.679 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.52
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Jack Phillips
Region: US
Website: acceleratediagnostics.com
Employees: 220
IPO year: 1996
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Accelerate Diagnostics, Inc. provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company was formerly known as Accelr8 Technology Corporation.

Recent news